Actionable news
All posts from Actionable news
Actionable news in AXON: Axovant Sciences Ltd,

Axovant Sinks on Rival's Alzheimer's Drug Setback

An Alzheimer's drug under development by Danish pharma Lundbeck failed a pivotal phase III study. The negative outcome sent shares of Axovant Sciences (AXON) falling in sympathy because it is developing a similar drug for Alzheimer's.

The Lundbeck drug...